Found: 14
Select item for more details and to access through your institution.
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37537-2
- By:
- Publication type:
- Article
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40022-5
- By:
- Publication type:
- Article
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Evaluation of Combined Chemotherapy and Genomic-Driven Targeted Therapy in Patient-Derived Xenografts Identifies New Therapeutic Approaches in Squamous Non-Small-Cell Lung Cancer Patients.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2785, doi. 10.3390/cancers16162785
- By:
- Publication type:
- Article
Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1 -Mutated Human Chordoma Xenograft.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1486, doi. 10.3390/cancers14061486
- By:
- Publication type:
- Article
PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 751, doi. 10.3390/cancers11060751
- By:
- Publication type:
- Article
HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 10, p. 2017, doi. 10.1002/1878-0261.13412
- By:
- Publication type:
- Article
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 531, p. 1, doi. 10.1126/scitranslmed.aax2625
- By:
- Publication type:
- Article
A large collection of integrated genomically characterized patient‐derived xenografts highlighting the heterogeneity of triple‐negative breast cancer.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 7, p. 1902, doi. 10.1002/ijc.32266
- By:
- Publication type:
- Article
Interaction between IGF2‐PI3K axis and cancer‐associated‐fibroblasts promotes anal squamous carcinogenesis.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 7, p. 1852, doi. 10.1002/ijc.32178
- By:
- Publication type:
- Article
Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 10, p. 2510, doi. 10.1002/ijc.29974
- By:
- Publication type:
- Article
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER<sup>+</sup> breast cancer.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 736, p. 1, doi. 10.1126/scitranslmed.adf9874
- By:
- Publication type:
- Article
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01158-3
- By:
- Publication type:
- Article
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17697-1
- By:
- Publication type:
- Article